Plasma microRNA signature is associated with risk stratification in prostate cancer patients.

Saved in:
Bibliographic Details
Title: Plasma microRNA signature is associated with risk stratification in prostate cancer patients.
Authors: Al-Qatati A; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany., Akrong C; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany., Stevic I; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany., Pantel K; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany., Awe J; Manitoba Institute of Cell Biology, Cancer Care Manitoba, University of Manitoba, Winnipeg, Canada., Saranchuk J; Manitoba Prostate Center, Cancer Care Manitoba, Winnipeg, Canada., Drachenberg D; Manitoba Prostate Center, Cancer Care Manitoba, Winnipeg, Canada., Mai S; Manitoba Institute of Cell Biology, Cancer Care Manitoba, University of Manitoba, Winnipeg, Canada., Schwarzenbach H; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Source: International journal of cancer [Int J Cancer] 2017 Sep 15; Vol. 141 (6), pp. 1231-1239. Date of Electronic Publication: 2017 Jun 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0215
DOI:10.1002/ijc.30815